Geron is a clinical stage biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Geron is a clinical stage biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Ask Geron Corp. to validate their program.
The move toward high-performance and high-value healthcare
In-depth analysis of the latest trends and solutions that improve heath outcomes, strengthen accountability, and cut costs
Actionable insights on how to drive better health outcomes at a far lower cost for your organization.
Profiles in innovative solutions and organizations that are “walking the walk” when it comes to delivering better savings, outcomes, and more
The move toward high-performance and high-value healthcare
In-depth analysis of the latest trends and solutions that improve heath outcomes, strengthen accountability, and cut costs
Actionable insights on how to drive better health outcomes at a far lower cost for your organization.
Profiles in innovative solutions and organizations that are “walking the walk” when it comes to delivering better savings, outcomes, and more